image
Collegium Pharmaceutical, Inc. COLL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 27.05
-2.7 %
$ 869 M
Market Cap
14.53
P/E
BALANCE SHEET
1.66 B ASSETS
45.51%
Growth Rates
1Year 45.51%
3Years 33.96%
5Years 40.27%
7Years 43.07%
10Years 78.42%
1.43 B LIABILITIES
51.36%
Growth Rates
1Year 51.36%
3Years 43.15%
5Years 45.65%
7Years 72.56%
10Years 55.52%
229 M EQUITY
17.10%
Growth Rates
1Year 17.10%
3Years 4.09%
5Years 21.22%
7Years 11.91%
10Years 35.39%
BALANCE SHEET DECOMPOSITION
Balance Sheet Collegium Pharmaceutical, Inc.
image
Current Assets 482 M
Cash & Short-Term Investments 163 M
Receivables 229 M
Other Current Assets 91 M
Non-Current Assets 1.18 B
Long-Term Investments 0
PP&E 20.2 M
Other Non-Current Assets 1.16 B
9.78 %13.74 %5.47 %69.80 %Total Assets$1.7b
Current Liabilities 510 M
Accounts Payable 3.93 M
Short-Term Debt 65.9 M
Other Current Liabilities 440 M
Non-Current Liabilities 925 M
Long-Term Debt 788 M
Other Non-Current Liabilities 137 M
4.59 %30.65 %54.92 %9.57 %Total Liabilities$1.4b

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 70.6 238.9 173.7 186.4 174.1 170.0 146.6 118.7 153.2 95.7 1.6 7.6
Short Term Investments 92.2 71.6 0 0 0 0 0 0 0 0 0 0
Receivables 228.5 179.5 183.1 105.8 83.3 73.0 77.9 10.0 2.1 0 0 0
Inventory 35.6 32.3 46.5 17.4 15.6 9.6 7.8 1.8 1.3 0 0 0
Other Current Assets 55.4 15.2 16.7 5.9 4.8 3.1 5.1 3.0 1.9 1.2 2.9 0.7
Total Current Assets 482.3 537.6 420.0 315.5 277.9 255.7 237.5 133.5 158.6 96.9 4.5 8.3
PP&E 20.2 22.0 26.4 27.1 27.4 20.9 9.3 1.8 1.0 0.7 0.5 0.7
Intangible Assets 891.4 421.7 567.5 268.7 335.9 29.5 44.3 0 2.1 0 0 0
Goodwill 162.3 133.9 133.7 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 2.5 2.5 2.5 0 0 97 K 97 K 97 K 0 0
Other Long Term Assets 9.4 1.9 100 K 87 K 2.7 0.2 0.2 0.2 0.3 0 80 K 80 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 663.6 1 143.3 1 174.1 692.1 643.8 306.3 291.2 135.6 162.0 97.7 5.1 9.0
LIABILITIES
Accounts Payable 3.9 8.7 3.5 4.2 10.0 6.2 12.2 5.7 9.1 3.5 2.2 1.2
Short Term Debt 65.9 184.3 164.7 50.0 49.0 5.1 1.6 1.5 2.7 2.7 6.2 0.3
Other Current Liabilities 424.5 256.8 261.2 222.2 178.7 190.4 175.3 24.3 8.9 2.2 2.0 1.1
Total Current Liabilities 509.5 457.9 270.1 230.4 191.2 197.3 187.5 31.5 22.9 5.8 10.4 2.6
Long Term Debt 787.9 490.0 545.6 209.6 218.4 17.1 9.9 0 1.5 4.2 6.9 0.8
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 137.3 0 0 0 0 0 0.7 0 0 0 0 59 K
Total Liabilities 1 434.7 947.9 979.3 489.1 457.8 218.9 199.7 31.5 27.1 12.6 17.3 3.5
EQUITY
Common Stock 40 K 38 K 37 K 36 K 35 K 34 K 33 K 33 K 29 K 21 K 8 K 1 K
Retained Earnings (164.0) (233.2) (281.3) (256.3) (333.1) (359.9) (337.2) (298.0) (223.2) (129.0) (101.8) (80.5)
Other Accumulative Comprehensive Income/Loss 55 K 14 K 0 0 0 0 0 (1.7) (1.3) (1.1) (0.9) (0.7)
Total Equity 228.8 195.4 194.8 202.9 186.0 87.4 91.6 104.1 134.9 85.1 (12.2) 5.6
Total Liabilities and Equity 1 663.6 1 143.3 1 174.1 692.1 643.8 306.3 291.2 135.6 162.0 97.7 5.1 9.0
SHARES OUTSTANDING
Common Shares Outstanding 32.3 33.7 33.8 34.9 34.4 33.5 32.9 30.3 24.3 13.5 7.5 7.5